- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05574075
Assessment of Motor Adaptation in Precision Grip Performance of Children
December 11, 2024 updated by: National Cheng-Kung University Hospital
Assessment of Motor Adaptation in Precision Grip Performance of Children: a Kinetic Analysis of Responsive Grip Behavior
Preterm children usually suffer from mild hand motor performance, however, the problem are rarely detected in time.
Identifying the pathology causing deficits in sensorimotor control of a hand helps the occupational therapist to determine appropriate clinical decision-making for intervention.
Well-motor performance requires complete sensorimotor control.
Understanding hand sensorimotor control mechanism and its neural control can help clinicians find the reason behind hand motor deficits.
The analysis of motion adaptation of the precision pinch behavior in the perturbing environment has been regarded as a clinically meaningful tool for evaluating sensorimotor control of a hand, especially for the complex anatomical structure of bone and tendon.
The motor adaptation analysis for the precision grip behavior can provide the temporal and spatial parameters of dynamic grip force adjustment.
Therefore, the exploration of motor adjustment can provide in-depth understanding of the neural mechanisms that lead to impairment of motor function and skill acquisition of a child, which can assist clinical occupational therapist in identifying the cause and severity of impairment of children's hand skills and provide appropriate strategies and types of treatment.
The recent research on children's motor adaptation focuses on the discussion of the efficiency of motor adaptation in unfamiliar or disturbing task situations.
Thus, the first purpose of this research is to develop an easy-to-detect apparatus to detect the adjustment efficiency of a responsive grip behavior of children in a disturbing pinch-lifting task and to construct the reliability of its evaluation.
The second purpose of the research is to understand the correlation between the efficiency of children's reactive pinch performance adjustment and the results of traditional evaluation of fine motor development scale and sensorimotor control assessments.
The third purpose of the research is to analyze the difference in motor adjustment of a precision pinch performance at different ages of preschool children.
The fourth purpose is to compare the efficiency of motor adaptation in preterm and term children.
In addition, preterm birth is often accompanied by white matter abnormalities and affects future hand motor performance.
Investigating white matter imaging markers for predicting motor adaptation can help early detection of problems.
Therefore, the fifth objective was to explore whether specific white matter imaging markers can predict the efficiency of reactive motor adaptation.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
65
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tainan, Taiwan, 704
- National Cheng-Kung University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 39 years (Child, Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
healthy adults: 20-39 years old term children: 24-60 months preterm children: 24-48 months
Description
Inclusion Criteria:
- Must be able to do reach-to-grasp performance
- Intact comprehension ability
Exclusion Criteria:
- Diagnosis of cerebral palsy and other genetic or congenital damage
- Bone and nerve damage in the upper limbs in the past year
- Un-correctable problems of vision or hearing impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
group of preterm and term children
group 1: preterm children group 2: term children
|
white matter imaging markers
|
|
group of different ages of preschool children
group 1: children with age of 25 months-36 months group 2: children with age of 37 months-48 months group 3: children with age of 49 months-60 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
responsive grip behavior
Time Frame: up to 2 years
|
amplitude of pinch force development or adaptation to perturbation
|
up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Bayley Scales of Infant and Toddler Development, Third Edition
Time Frame: up to 2 years
|
for diagnosing developmental delays in early childhood
|
up to 2 years
|
|
Peabody Developmental Motor Scales, Second Edition
Time Frame: up to 2 years
|
measure interrelated motor abilities of children from birth through age 5 years of age
|
up to 2 years
|
|
Tuning Fork 128 Hz
Time Frame: up to 2 years
|
measure vibration sense
|
up to 2 years
|
|
Box and blocks test
Time Frame: up to 2 years
|
measure upper limb coordination
|
up to 2 years
|
|
Semmes-Weinstein monofilament test
Time Frame: up to 2 years
|
measure touch-pressure sense
|
up to 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 12, 2023
Primary Completion (Actual)
September 9, 2024
Study Completion (Actual)
September 12, 2024
Study Registration Dates
First Submitted
October 5, 2022
First Submitted That Met QC Criteria
October 6, 2022
First Posted (Actual)
October 10, 2022
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 11, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- B-BR-110-072
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diffusion tensor imaging
-
Assistance Publique - Hôpitaux de ParisUnknownHearing Loss | Encephalopathy | SUSAC's Syndrome | Retinal Artery Branch OcclusionsFrance
-
The Hospital for Sick ChildrenCompletedEpilepsy | Focal Cortical DysplasiaCanada
-
CCTU- Cancer ThemeCambridge University Hospitals NHS Foundation Trust; Cancer Research UK; Experimental...CompletedHigh Grade GliomaUnited Kingdom
-
Children's Healthcare of AtlantaCompleted
-
The Hospital for Sick ChildrenCompletedPartial Epilepsy | Localization-related EpilepsyCanada
-
Centre Hospitalier Universitaire de NīmesCompletedAntiphospholipid SyndromeFrance
-
Cedars-Sinai Medical CenterCompletedCervical Spine HerniationUnited States
-
Johns Hopkins UniversityHugo W. Moser Research Institute at Kennedy Krieger, Inc.CompletedBrain Injury, Fetus and NeonateUnited States